OKYO PHARMA LTD SP.ADR/65 (OK10) — Financial Flexibility Index
Latest as of March 2025:
-0.20x
OKYO PHARMA LTD SP.ADR/65 (OK10) has a Financial Flexibility Index of -0.20x as of March 2025. Free cash flow of €-1.81 Million (operating CF €-1.81 Million minus capex €1.21K) represents 0% of total liabilities (€9.23 Million).
Financial Flexibility Index
-0.20x
Free Cash Flow / Total Liabilities
Free Cash Flow
€-1.81 Million
Operating CF − Capex
Total Liabilities
€9.23 Million
EUR
Capital Expenditures
€1.21K
EUR
OKYO PHARMA LTD SP.ADR/65 Financial Flexibility Index (2022–2025)
Historical Financial Flexibility Index trend for OKYO PHARMA LTD SP.ADR/65 across 4 annual periods. See OK10 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for OKYO PHARMA LTD SP.ADR/65 (2022–2025)
Year-by-year free cash flow to debt coverage for OKYO PHARMA LTD SP.ADR/65. For the full company profile including market capitalisation, see market value of OKYO PHARMA LTD SP.ADR/65.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.20x | €-1.81 Million | €-1.81 Million | €9.23 Million | ▲ +84.7% |
| 2024 | -1.28x | €-9.49 Million | €-9.49 Million | €7.42 Million | ▼ -20.7% |
| 2023 | -1.06x | €-7.69 Million | €-7.70 Million | €7.26 Million | ▲ +73.8% |
| 2022 | -4.04x | €-5.47 Million | €-5.47 Million | €1.35 Million | — |
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities